ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd. specializes in the production of custom antibodies and related services, catering to clients across the United States, Canada, Europe, and beyond. Founded in 1989 and headquartered in Fargo, North Dakota, the company offers a comprehensive range of services including B cell sorting, phage display production, antibody engineering, and hybridoma production. Additionally, it provides advanced capabilities in antibody optimization, epitope mapping, and custom antigen design. ImmunoPrecise operates state-of-the-art laboratory facilities in Victoria, British Columbia, and has a subsidiary in the Netherlands. The company collaborates with various institutions, including the University of Victoria and Zymeworks Inc., to develop innovative solutions for detecting and treating diseases such as COVID-19. With a focus on therapeutic, diagnostic, and research applications, ImmunoPrecise employs a skilled team of R&D scientists and utilizes proprietary technologies to enhance the efficiency of antibody production.